RAPT Therapeutics (RAPT) Gross Margin: 2020-2022
Historic Gross Margin for Therapeutics (RAPT) over the last 2 years, with Jun 2022 value amounting to 100.00%.
- Therapeutics' Gross Margin changed negligibly% to 100.00% in Q2 2022 from the same period last year, while for Jun 2022 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2022, which is negligibly% changed negligibly from last year.
- Per Therapeutics' latest filing, its Gross Margin stood at 100.00% for Q2 2022, which was down 0.00% from 100.00% recorded in Q1 2022.
- In the past 5 years, Therapeutics' Gross Margin ranged from a high of 100.00% in Q1 2020 and a low of 100.00% during Q1 2020.
- Its 3-year average for Gross Margin is 100.00%, with a median of 100.00% in 2022.